Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.73 |
| ▸ | ITGAV | P06756 | 20/20 | 0.73 |
| ▸ | ITGB1 | P05556 | 17/20 | 0.56 |
| ▸ | ITGA5 | P08648 | 17/20 | 0.56 |
| ▸ | ITGB6 | P18564 | 1/20 | 0.49 |
| ▸ | ITGB5 | P18084 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6504253 | 0.92 | ITGB3 (0.61) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6180607 | 0.87 | ITGB3 (0.74) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6175851 | 0.85 | ITGB3 (0.74) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6178889 | 0.85 | ITGB3 (0.74) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6175847 | 0.85 | ITGB3 (0.74) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6176294 | 0.84 | ITGB3 (0.73) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6176301 | 0.84 | ITGB3 (1.00) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6177136 | 0.84 | ITGB3 (1.00) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL6177505 | 0.82 | ITGB3 (0.75) | ITGB3ITGAVITGB1ITGA5ITGB6 | |
| SCHEMBL1822558 | 0.82 | ITGB3 (0.69) | ITGB3ITGAVITGB1ITGA5ITGB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6897231-B2 | Indazole derivatives as JNK inhibitors and compositions and methods related thereto | SIGNAL PHARMACEUTICALS, INC. (US) | 2005-05-24 | — | — | US | claimed |
| EP-1218005-B1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-12-15 | — | — | EP | claimed |
| US-6881736-B1 | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2005-04-19 | — | — | US | disclosed |
| US-6881736-B1 | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2005-04-19 | — | — | US | disclosed |
| US-6881736-B1 | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2005-04-19 | — | — | US | disclosed |
| EP-1218005-B1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-12-15 | — | — | EP | disclosed |
| EP-1218005-A4 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2002-10-09 | — | — | EP | disclosed |
| EP-1218005-A2 | VITRONECTIN RECEPTOR ANTAGONISTS | SmithKline Beecham Corporation (US) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001017959-A2 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-03-15 | — | — | WO | disclosed |